XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses        
Research and development expenses, net of government assistance $ (2,976) $ (460) $ (5,684) $ (1,555)
General and administrative (1,855) (1,632) (4,109) (3,506)
Restructuring cost 0 0 0 (1,485)
Loss from operating activities (4,831) (2,092) (9,793) (6,546)
Foreign exchange gain (loss) 13 (13) 5 (5)
Change in fair value of derivative warrant liabilities 362 (1,826) 1,756 (1,826)
Interest and other income, net 172 212 407 346
Total other income (expenses), net 547 (1,627) 2,168 (1,485)
Loss before income tax benefit (4,284) (3,719) (7,625) (8,031)
Income tax benefit 852 446 1,576 735
Net loss (3,432) (3,273) (6,049) (7,296)
Total comprehensive loss $ (3,432) $ (3,273) $ (6,049) $ (7,296)
Basic loss per share (in dollars per share) $ (0.3) $ (0.43) $ (0.53) $ (0.97)
Diluted loss per share (in dollars per share) $ (0.3) $ (0.43) $ (0.53) $ (0.97)
Weighted average number of shares outstanding 11,506,234 7,552,677 11,506,234 7,494,425
Weighted-average number of shares outstanding, diluted (in shares) 11,506,234 7,552,677 11,506,234 7,494,425